Bempedoic acid is a medicine that lowers "bad" LDL cholesterol and helps prevent heart attacks and strokes, often for people who can't take statins. It is a pill taken once a day. It works by slowing down how much cholesterol the liver makes.
Every report comes from a Lived member, sent anonymously.
Have you tried Nexletol (Bempedoic Acid) for High Cholesterol (Hypercholesterolemia)?
Bempedoic acid, sold as Nexletol, is a once-daily prescription tablet that lowers LDL (low-density lipoprotein) cholesterol, the "bad" cholesterol that builds up in artery walls and raises the risk of heart attack and stroke. It is mainly used by adults who need more cholesterol lowering than they are getting, especially people who cannot take a statin, or cannot take a full statin dose, because of side effects such as muscle aches. It has two approved uses in adults. It lowers the risk of major heart events, a combined measure of heart attack, stroke, death from heart disease and procedures to reopen blocked heart arteries, in people at increased risk of these events who are unable to take recommended statin therapy, including people taking no statin at all. In the main trial, that benefit came mostly from fewer heart attacks and artery-opening procedures (see What to Expect). It also lowers LDL cholesterol in adults with high cholesterol, including heterozygous familial hypercholesterolemia, an inherited condition that causes high LDL from birth. For that use it can be added to a statin or other cholesterol medicines, or used alone when those are not possible. Nexlizet is a separate brand that combines bempedoic acid with ezetimibe, another cholesterol medicine that reduces how much cholesterol the gut absorbs. It is approved for lowering LDL cholesterol, and its bempedoic acid component carries the same heart-event risk-reduction approval as Nexletol. It also adds ezetimibe's own instructions and interactions.
Most of the cholesterol in the blood is made by the liver. Bempedoic acid blocks a liver enzyme called ACL (ATP-citrate lyase), which works early in the liver's cholesterol-making process, a step before the one statins block. With less cholesterol being made, liver cells pull more LDL out of the bloodstream to make up the difference, so blood LDL levels fall. Bempedoic acid has to be switched on by an enzyme that is found mainly in the liver, so most of its action happens there. That may help explain why, in trials, muscle-related side effects were generally uncommon, which matters for people who stopped statins because of muscle aches, but this explanation has not been proven. Some muscle complaints, such as muscle spasms and pain in the arms or legs, were still reported somewhat more often than with placebo (see Side Effects).
Nexletol is one 180 mg tablet taken by mouth once a day, with or without food. There is a single standard dose, so treatment does not involve working up through several strengths. For either Nexletol or Nexlizet, a missed dose is taken as soon as remembered unless the next dose is nearly due, in which case it is skipped; do not double up. Nexlizet is one tablet a day containing 180 mg of bempedoic acid and 10 mg of ezetimibe. It should be swallowed whole. People who also take a bile acid sequestrant, an older cholesterol medicine such as cholestyramine or colesevelam that binds other drugs in the gut, should take Nexlizet at least 2 hours before or at least 4 hours after it.
Most people take bempedoic acid without major problems. The more common effects in trials included muscle spasms, back pain, pain in the arms or legs, stomach discomfort and colds or bronchitis. Blood tests may show a mild drop in hemoglobin (anemia), a rise in liver enzymes or a small rise in creatinine, a marker of kidney function. These lab changes usually appear in the first month, persist while taking it and go back to baseline after stopping. Gallstones were also somewhat more common than with placebo in the large outcome trial. Bempedoic acid raises uric acid, the waste product that causes gout when it builds up. The increase usually shows up within the first four weeks and lasts as long as treatment continues. In the large heart outcome trial, gout occurred in about 3 in 100 people taking it, compared with about 2 in 100 on placebo. A suddenly painful, hot, swollen joint, often the big toe, is worth reporting so it can be treated. Tendon tears are uncommon but serious. They have involved the shoulder (rotator cuff), the biceps tendon and the Achilles tendon at the back of the ankle, and occurred within weeks to months of starting. The risk is higher in people over 60, those taking corticosteroids or fluoroquinolone antibiotics (such as ciprofloxacin or levofloxacin), people with kidney failure and anyone with past tendon problems. At the first sign of tendon pain, swelling or a sudden snap, rest the area and contact the prescriber promptly; the medicine is stopped if a tendon ruptures.
Bempedoic acid raises blood levels of two statins. It should not be combined with simvastatin at doses above 20 mg a day or pravastatin above 40 mg a day, because the higher statin levels increase the risk of muscle injury. Taking it with a fibrate (a triglyceride-lowering medicine such as fenofibrate) has sometimes raised triglycerides and lowered high-density lipoprotein (HDL) cholesterol, the "good" cholesterol, so those levels are checked about four weeks after the two are started together. Nexlizet has extra interactions from its ezetimibe component: it raises levels of cyclosporine (an immune-suppressing medicine used after organ transplants and for some autoimmune conditions), so cyclosporine levels are monitored if the two are taken together, and fibrates other than fenofibrate are not recommended with it because of gallstone risk. Tell the prescriber and pharmacist about all medicines, especially other cholesterol drugs, steroids and antibiotics. People who have had a serious allergic reaction to bempedoic acid should not take it. Serious reactions, including angioedema (rapid swelling of the face, lips, tongue or throat), have been reported; swelling that affects breathing or swallowing needs emergency care. Bempedoic acid may harm a developing baby, and lowering cholesterol is generally not needed during pregnancy, so it is usually stopped once pregnancy is recognized. It passes into breast milk in small amounts and may affect a breastfed infant, so breastfeeding plans should be discussed before starting. A past tendon problem or tendon tear usually means another medicine is preferred, so mention any such history before starting.
The cholesterol-lowering effect builds quickly and reaches its peak within about four weeks, though people do not feel high cholesterol or its improvement. A blood test 8 to 12 weeks after starting shows how much LDL has come down. Added to a statin, it lowered LDL by about 18 percent more than placebo did; in people not taking statins, the extra drop was about 20 percent. For someone starting with an LDL of 140, that is roughly 25 to 30 points lower. That is often not enough on its own to reach a target, which is why it is frequently combined with ezetimibe or other treatments. In the large trial of about 14,000 people who could not tolerate statins, followed for a median of about three and a half years, a major heart event (heart attack, stroke, death from heart disease or a procedure to open a heart artery) occurred in 11.7% of people on bempedoic acid and 13.3% on placebo. The clearest reductions were in heart attacks and artery-opening procedures; the trial did not show a significant effect on stroke, death from heart disease or overall survival. Like other cholesterol medicines, it works only while it is being taken, so it is usually a long-term treatment alongside diet, activity and control of blood pressure and blood sugar. Follow-up visits check cholesterol and may include uric acid, kidney function and blood counts.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Nexletol (Bempedoic Acid), what you've noticed, or ask the community a question.